Mitochondrial morphodynamics alteration induced by influenza virus infection as a new antiviral strategy.


Journal

PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921

Informations de publication

Date de publication:
02 2021
Historique:
received: 06 07 2020
accepted: 27 01 2021
revised: 01 03 2021
pubmed: 18 2 2021
medline: 24 6 2021
entrez: 17 2 2021
Statut: epublish

Résumé

Influenza virus infections are major public health threats due to their high rates of morbidity and mortality. Upon influenza virus entry, host cells experience modifications of endomembranes, including those used for virus trafficking and replication. Here we report that influenza virus infection modifies mitochondrial morphodynamics by promoting mitochondria elongation and altering endoplasmic reticulum-mitochondria tethering in host cells. Expression of the viral RNA recapitulates these modifications inside cells. Virus induced mitochondria hyper-elongation was promoted by fission associated protein DRP1 relocalization to the cytosol, enhancing a pro-fusion status. We show that altering mitochondrial hyper-fusion with Mito-C, a novel pro-fission compound, not only restores mitochondrial morphodynamics and endoplasmic reticulum-mitochondria contact sites but also dramatically reduces influenza replication. Finally, we demonstrate that the observed Mito-C antiviral property is directly connected with the innate immunity signaling RIG-I complex at mitochondria. Our data highlight the importance of a functional interchange between mitochondrial morphodynamics and innate immunity machineries in the context of influenza viral infection.

Identifiants

pubmed: 33596274
doi: 10.1371/journal.ppat.1009340
pii: PPATHOGENS-D-20-01460
pmc: PMC7920353
doi:

Substances chimiques

Antiviral Agents 0
Pharmaceutical Preparations 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1009340

Commentaires et corrections

Type : ErratumIn

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Nature. 2008 Dec 4;456(7222):605-10
pubmed: 19052620
Biomed Res Int. 2014;2014:498083
pubmed: 24779013
Mol Cell. 2020 Dec 3;80(5):810-827.e7
pubmed: 33171123
Mol Cell. 2005 Sep 16;19(6):727-40
pubmed: 16153868
Lancet. 2018 Mar 31;391(10127):1285-1300
pubmed: 29248255
Nat Microbiol. 2018 Dec;3(12):1369-1376
pubmed: 30478388
Antioxidants (Basel). 2018 Dec 08;7(12):
pubmed: 30544804
Rev Med Virol. 2016 May;26(3):146-60
pubmed: 26817660
Methods Mol Biol. 2017;1594:43-71
pubmed: 28456976
Proc Natl Acad Sci U S A. 2011 Aug 30;108(35):14590-5
pubmed: 21844353
Virusdisease. 2016 Dec;27(4):357-368
pubmed: 28004015
Science. 2006 Nov 10;314(5801):994-7
pubmed: 17038590
J Virol. 2020 Jan 6;94(2):
pubmed: 31694945
Nature. 2005 Oct 20;437(7062):1167-72
pubmed: 16177806
Cell. 2005 Sep 9;122(5):669-82
pubmed: 16125763
J Immunol. 2014 Sep 15;193(6):3080-9
pubmed: 25135833
Nat Commun. 2014 Aug 20;5:4713
pubmed: 25140902
Autophagy. 2009 Apr;5(3):321-8
pubmed: 19066474
EMBO Rep. 2010 Feb;11(2):133-8
pubmed: 20019757
Nat Rev Microbiol. 2008 May;6(5):363-74
pubmed: 18414501
Proc Natl Acad Sci U S A. 2017 Aug 1;114(31):8277-8282
pubmed: 28716905
Clin Infect Dis. 2020 Oct 23;71(7):1790-1794
pubmed: 32020174
Nat Immunol. 2005 Oct;6(10):981-8
pubmed: 16127453
Nat Immunol. 2006 Jan;7(1):40-8
pubmed: 16286919
Science. 2006 Nov 10;314(5801):997-1001
pubmed: 17038589
PLoS Pathog. 2013;9(12):e1003722
pubmed: 24339771
Ann Intern Med. 2012 Apr 3;156(7):512-24
pubmed: 22371849
EMBO Rep. 2020 Dec 3;21(12):e49019
pubmed: 33180995
Cell Host Microbe. 2016 Sep 14;20(3):342-356
pubmed: 27545046
Virus Res. 2015 Nov 2;209:11-22
pubmed: 25678267
J Biol Chem. 2006 Dec 8;281(49):37972-9
pubmed: 17003040

Auteurs

Irene Pila-Castellanos (I)

ENYO-Pharma, Lyon, France.
Institut Necker-Enfants Malades (INEM), INSERM U1151-CNRS UMR 8253, Université de Paris, Paris, France.

Diana Molino (D)

Institut Necker-Enfants Malades (INEM), INSERM U1151-CNRS UMR 8253, Université de Paris, Paris, France.

Joe McKellar (J)

Institut de Recherche en Infectiologie de Montpellier (IRIM), UMR 9004-CNRS, Université de Montpellier, Montpellier, France.

Laetitia Lines (L)

ENYO-Pharma, Lyon, France.

Juliane Da Graca (J)

Institut Necker-Enfants Malades (INEM), INSERM U1151-CNRS UMR 8253, Université de Paris, Paris, France.

Marine Tauziet (M)

Institut de Recherche en Infectiologie de Montpellier (IRIM), UMR 9004-CNRS, Université de Montpellier, Montpellier, France.

Ivan Mikaelian (I)

Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de recherche en cancérologie de Lyon, Lyon, France.

Laurène Meyniel-Schicklin (L)

ENYO-Pharma, Lyon, France.

Patrice Codogno (P)

Institut Necker-Enfants Malades (INEM), INSERM U1151-CNRS UMR 8253, Université de Paris, Paris, France.

Cédric Delevoye (C)

Institut Curie, PSL Research University, CNRS, UMR144, Structure and Membrane Compartments Paris, France.
Institut Curie, PSL Research University, CNRS, UMR144, Cell and Tissue Imaging Facility (PICT-IBiSA), Paris, France.

Olivier Moncorgé (O)

Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de recherche en cancérologie de Lyon, Lyon, France.

Eric Meldrum (E)

ENYO-Pharma, Lyon, France.

Caroline Goujon (C)

Université de Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de recherche en cancérologie de Lyon, Lyon, France.

Etienne Morel (E)

Institut Necker-Enfants Malades (INEM), INSERM U1151-CNRS UMR 8253, Université de Paris, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH